2020 Virtual ESMO Review
2020 ESMO Update on CDK 4/6 in Adjuvant HR+, HER2- EBC: Does the Addition of Abemaciclib to Hormonal Therapy Reduce the Risk of Cancer Recurrence?
By
2020 Virtual ESMO Review
FEATURING
Lee Schwartzberg
By
2020 Virtual ESMO Review
FEATURING
Lee Schwartzberg
Comments 0
Login to view comments.
Click here to Login
